T for immune responses to breast cancer has been very much like the search for the giant panda. A few individuals, on the basis of scant and equivocal evidence, believed a meaningful kind of immunity existed in some patients with clinical breast cancer. A great deal of time and money produced a few more hints, most ( onvincing to those who were already believers. H;rrtl evidence was difficult to obtain.
No takes yet. Share an insight, caveat, or question.
John W. Berg (1971) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: